UNLOCK BIOAVAILABILITY
CONTROL RELEASE, ELEVATE OUTCOMES
NOVEL DRUG DELIVERY SYSTEMS (NDDS)
Our Novel Delivery team engineers polymeric, lipid, and nano-enabled systems that solve solubility, stability, and targeting challenges. Using in-silico screening and IVIVC modelling, we craft matrices that release over hours, particles that home to inflamed tissue, and
formulations that bypass first-pass metabolism—each ready for scale-out.
formulations that bypass first-pass metabolism—each ready for scale-out.
Controlled-Release Matrices
Targeted Particles
Solubility Boosters
IVIVC (In Vitro–In Vivo Correlation)